Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Lojuxta 10mg hard capsules {equilateral_black_triangle}

Active Ingredient:
lomitapide mesylate
Company:  
Amryt Pharmaceuticals DAC See contact details
ATC code: 
C10AX12
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials HCP Med Info
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Lojuxta (lomitapide) Healthcare Professional Guide

{healthcare_pro_orange} For Healthcare Professionals
Healthcare professional guide contains information on the serious risks associated with Lojuxta and how to help mitigate these risks.
{pdf_link}

Lojuxta Alert Card

The purpose of the patient alert card is to inform health care professionals of potential drug-drug interactions before any additional medicinal product is taken. Patients will be instructed to carry this card and show it to all doctors and pharmacists involved in their treatment.
{pdf_link}

Lojuxta Patient Care Guide

Patient care guide containing important safety information for patients treated with Lojuxta (lomitapide).

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Amryt Pharmaceuticals DAC
Company image
Address
45 Mespil Road, Dublin4, D04 W2F1, Ireland
WWW
http://www.amrytpharma.com
Telephone
+353 1 518 0200
Medical Information Direct Line
+44 1604 549 952
Medical Information e-mail
[email protected]
Customer Care direct line
00800 4447 4447